And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...
Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...
Overdiagnosis in the inpatient setting poses significant challenges, including unnecessary treatments and harms to patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results